LANXESS to showcase Biosecurity Solutions at EuroTier 2022
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
The inspection concluded with no observation (FDA-483) issued.
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
On the precision oncology front, expanded larotrectinib data will focus on efficacy and safety findings for pediatric and adult patients with NTRK gene fusion-positive solid tumors
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
Subscribe To Our Newsletter & Stay Updated